Recently, Eggers H, et al pinpointed that HIC1 hypermethylation was associated with reduced recurrence-free survival in renal cell carcinoma (RCC), suggesting that HIC1 could be seen as a possible marker to improve individualized therapy and risk stratification [13]. This evidence concerns the gene HIC1 and hereditary clear cell renal cell carcinoma.